Speakers

Professor Jemma Hopewell leads a team of genetic epidemiologists, clinical fellows, medical statisticians and bioinformaticians in a programme of research focusing on the use of genetic and clinical trial-based studies to investigate the causes and treatments for cardiovascular disease and arrhythmias. 

She has particular interests in using epidemiological, genetic and other large-scale 'omic approaches to improve our understanding of drug targets and disease mechanisms, perform genomic characterisation of vascular disease and its risk factors, particularly Lp(a), and in determining predictors of patient response to therapy. 

Jemma leads and collaborates on numerous trial-based, epidemiological, and genetic epidemiological projects involving the Clinical Trials Service Unit and Epidemiological Studies Unit (CTSU)'s vascular mega-trials (such as HPS, SEARCH, THRIVE, REVEAL), large-scale studies and biobanks (such as PROCARDIS, UK Biobank), and international consortia (such as CARDIoGRAMplusC4D), and working with colleagues from across academia and other industries. 

She has steering committee, data monitoring committee, and invited expert roles in numerous large-scale studies and clinical trials, as well as for national agencies and funders, ranging from the Lp(a) Scientific Advisory Board, to MHRA, British Heart Foundation Project Grants Committee Member, to Chairing the American Heart Association Fellowship Committee (Human Studies 22-23).